AI-Powered Nanotechnology for Combating Infectious Diseases

Infectious diseases remain a critical global health challenge, disproportionately affecting developing nations where healthcare infrastructure and diagnostic capabilities are limited. Conventional diagnostic methods, including culture-based techniques and polymerase chain reaction, face significant limitations such as extended turnaround times, insufficient sensitivity, and vulnerability to genetic mutations in emerging pathogen variants. The convergence of artificial intelligence and nanotechnology has introduced transformative solutions that address these fundamental shortcomings through AI-enhanced biosensors, smart nanodevices, and personalized treatment platforms. This comprehensive review examines the synergistic integration of AI and nanotechnology in combating infectious diseases, focusing on diagnostic innovations, therapeutic applications, and clinical implementations. Nanomaterials, including metallic nanoparticles, carbon-based structures, polymeric systems, lipid-based carriers, and quantum dots, demonstrate unique physicochemical properties enabling ultra-sensitive pathogen detection and targeted drug delivery. Machine learning algorithms enhance these capabilities by processing complex biological data, optimizing nanomaterial properties, and enabling predictive analytics for early disease detection. Deep learning models, particularly convolutional neural networks, have revolutionized pathogen identification through analysis of microscopic images and genomic sequences, achieving diagnostic accuracy exceeding 95% in multiple applications. The review also addresses critical challenges, including data privacy concerns, algorithmic bias, regulatory hurdles, and infrastructure barriers that must be overcome for widespread clinical translation. The integration of AI and nanotechnology represents a paradigm shift from reactive diagnostic approaches towards proactive, precision-based methodologies, offering unprecedented opportunities to transform infectious disease management and advance global health equity.